291 related articles for article (PubMed ID: 3035380)
1. Myristylation of picornavirus capsid protein VP4 and its structural significance.
Chow M; Newman JF; Filman D; Hogle JM; Rowlands DJ; Brown F
Nature; 1987 Jun 11-17; 327(6122):482-6. PubMed ID: 3035380
[TBL] [Abstract][Full Text] [Related]
2. Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.
Moscufo N; Chow M
J Virol; 1992 Dec; 66(12):6849-57. PubMed ID: 1331497
[TBL] [Abstract][Full Text] [Related]
3. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
[TBL] [Abstract][Full Text] [Related]
4. Maturation of poliovirus capsid proteins.
Hellen CU; Wimmer E
Virology; 1992 Apr; 187(2):391-7. PubMed ID: 1312265
[No Abstract] [Full Text] [Related]
5. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence.
Marc D; Drugeon G; Haenni AL; Girard M; van der Werf S
EMBO J; 1989 Sep; 8(9):2661-8. PubMed ID: 2555183
[TBL] [Abstract][Full Text] [Related]
6. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.
Curry S; Fry E; Blakemore W; Abu-Ghazaleh R; Jackson T; King A; Lea S; Newman J; Stuart D
J Virol; 1997 Dec; 71(12):9743-52. PubMed ID: 9371640
[TBL] [Abstract][Full Text] [Related]
8. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
Marc D; Masson G; Girard M; van der Werf S
J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
[TBL] [Abstract][Full Text] [Related]
9. Efficient analysis of nonviable poliovirus capsid mutants.
Simons J; Rogove A; Moscufo N; Reynolds C; Chow M
J Virol; 1993 Mar; 67(3):1734-8. PubMed ID: 8382319
[TBL] [Abstract][Full Text] [Related]
10. Capsid protein VP4 of poliovirus is N-myristoylated.
Paul AV; Schultz A; Pincus SE; Oroszlan S; Wimmer E
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7827-31. PubMed ID: 2825164
[TBL] [Abstract][Full Text] [Related]
11. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes.
Lentz KN; Smith AD; Geisler SC; Cox S; Buontempo P; Skelton A; DeMartino J; Rozhon E; Schwartz J; Girijavallabhan V; O'Connell J; Arnold E
Structure; 1997 Jul; 5(7):961-78. PubMed ID: 9261087
[TBL] [Abstract][Full Text] [Related]
12. Implications of the picornavirus capsid structure for polyprotein processing.
Arnold E; Luo M; Vriend G; Rossmann MG; Palmenberg AC; Parks GD; Nicklin MJ; Wimmer E
Proc Natl Acad Sci U S A; 1987 Jan; 84(1):21-5. PubMed ID: 3467351
[TBL] [Abstract][Full Text] [Related]
13. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.
Rhee SS; Hunter E
J Virol; 1987 Apr; 61(4):1045-53. PubMed ID: 3493352
[TBL] [Abstract][Full Text] [Related]
14. Post-translational modifications of poliovirus proteins.
Urzainqui A; Carrasco L
Biochem Biophys Res Commun; 1989 Jan; 158(1):263-71. PubMed ID: 2536278
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.
Tesar M; Jia XY; Summers DF; Ehrenfeld E
Virology; 1993 Jun; 194(2):616-26. PubMed ID: 8389076
[TBL] [Abstract][Full Text] [Related]
16. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes.
Martín-Belmonte F; López-Guerrero JA; Carrasco L; Alonso MA
Biochemistry; 2000 Feb; 39(5):1083-90. PubMed ID: 10653654
[TBL] [Abstract][Full Text] [Related]
17. Myristylation of rotavirus proteins.
Clark B; Desselberger U
J Gen Virol; 1988 Oct; 69 ( Pt 10)():2681-6. PubMed ID: 2844975
[TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D.
Mattion NM; Reilly PA; Camposano E; Wu SL; DiMichele SJ; Ishizaka ST; Fantini SE; Crowley JC; Weeks-Levy C
J Virol; 1995 Aug; 69(8):5132-7. PubMed ID: 7609083
[TBL] [Abstract][Full Text] [Related]
19. trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins.
Jia XY; Van Eden M; Busch MG; Ehrenfeld E; Summers DF
J Virol; 1998 Oct; 72(10):7972-7. PubMed ID: 9733835
[TBL] [Abstract][Full Text] [Related]
20. Myristoyl modification of viral proteins: assays to assess functional roles.
Chow M; Moscufo N
Methods Enzymol; 1995; 250():495-509. PubMed ID: 7651174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
